Gahleitner, L., Braun, C., Binder-Blaser, V., Willier, S., Vallée, T., Schmid, I., Albert, M., Klein, C., Feuchtinger, T. (2025). Increased dosing of blinatumomab in children and adolescents with Relapsed/Refractory B-lineage acute lymphoblastic leukemia – beneficial safety profile with 30µg/m²/day in a single center study. Blood. https://doi.org/10.1182/blood-2025-6857